Depixus Overview
- Founded
-
2012

- Status
-
Private
- Employees
-
63

- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$34.9M
- Investors
-
8
Depixus General Information
Description
Developer of a single molecule genetic and epigenetic sequencing technology intended to offer extraction of genetic and epigenetic information from single molecules of DNA and RNA. The company's SIMDEQ (SIngle-molecule Magnetic DEtection and Quantification) technology permits a full genome or genomic region to be analyzed quickly and easily on a single integrated platform, with the investigator to specify the level of sequence and epigenetic detail required, enabling doctors with simple sample-preparation, sequential DNA fingerprinting, full-sequencing and epityping to avail a fast time-to-result.
Contact Information
- 3-5 Impasse Reille
- 75014 Paris
- France
Depixus Timeline
Depixus Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC (Series A) | 15-Dec-2021 | $34.9M | 000.00 | 000.00 | Completed | Generating Revenue |
6. Grant | 01-May-2019 | 00.000 | 00.000 | Completed | Generating Revenue | |
5. Grant | 00000 | 00.000 | Completed | Generating Revenue | ||
4. Later Stage VC | 31-Dec-2018 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
3. Later Stage VC | 29-Mar-2018 | 00.000 | 00.000 | 00.000 | Completed | Generating Revenue |
2. Seed Round | 04-Sep-2017 | $2.33M | $2.33M | 00.000 | Completed | Generating Revenue |
1. Accelerator/Incubator | 26-Nov-2013 | Completed | Generating Revenue |
Depixus Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Depixus Comparisons
Industry
Depixus Competitors (17)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Quantapore | Venture Capital-Backed | South San Francisco, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
000 00000000000 | Venture Capital-Backed | London, United Kingdom | 000 | 000.00 | 00000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | San Diego, CA | 00 | 0000 | 00000 00000 | |
000000 00000000 00 | Formerly VC-backed | Oxford, United Kingdom | 000 | 00.000 | 00000000 | 00.000 |
000000 00000 | Corporate Backed or Acquired | Carlsbad, CA | 00 | 000000000000 |
Depixus Patents
Depixus Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3686642-A1 | Multichannel close-up imaging device | Withdrawn | 24-Jan-2019 | 0000000000 | 00 |
EP-3914949-A1 | Multichannel close-up imaging device | Pending | 24-Jan-2019 | 0000000000 | |
CA-3123151-A1 | Method of nucleic acid enrichment using site-specific nucleases followed by capture | Pending | 12-Dec-2018 | 0000000000 | |
AU-2019398707-A1 | Method of nucleic acid enrichment using site-specific nucleases followed by capture | Pending | 12-Dec-2018 | 0000000000 | |
EP-3837379-A1 | Method of nucleic acid enrichment using site-specific nucleases followed by capture | Pending | 12-Dec-2018 | C12Q1/6806 |
Depixus Executive Team (6)
Depixus Board Members (9)
Name | Representing | Role | Since |
---|---|---|---|
John Berriman | Self | Chairman | 000 0000 |
Lachlan MacKinnon | Lansdowne Partners | Board Member | 000 0000 |
Mark Chin | Arix Bioscience | Board Member | 000 0000 |
Ronald Lindsay Ph.D | Self | Board Member | 000 0000 |
Stephen Allen Ph.D | Depixus | Chief Business Officer & Board Member | 000 0000 |
Depixus Signals
Depixus Investors (8)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | |
Casdin Capital | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Lansdowne Partners | Hedge Fund | Minority | 000 0000 | 000000 0 | |
Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 | ||
Innovate UK | Government | 000 0000 | 000000 0 |